| Sharon Bio-Medicine Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532908 |
NSE Symbol : - |
P/E(TTM) : 2.01 |
|
ISIN Demat : INE028B01029 |
Div & Yield% : - |
EPS(TTM) : 1.60 |
|
Book Value(₹) : -47.76 |
Market Cap(₹Cr) : 38.18 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
| Gross Sales | 43.00 | 56.39 | 53.95 | 36.90 | 48.53 | 42.81 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 43.00 | 56.39 | 53.95 | 36.90 | 48.53 | 42.81 |
| Other Operating Income | 1.23 | 1.36 | 1.21 | 0.94 | 1.24 | 1.55 |
| Other Income | 0.79 | 2.09 | 0.85 | 0.72 | 1.13 | 0.56 |
| Total Income | 45.03 | 59.83 | 56.02 | 38.55 | 50.90 | 44.91 |
| Total Expenditure | 40.72 | 47.45 | 44.47 | 36.99 | 43.39 | 38.01 |
| PBIDT | 4.31 | 12.39 | 11.55 | 1.57 | 7.51 | 6.90 |
| Interest | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 |
| PBDT | 4.29 | 12.37 | 11.53 | 1.55 | 7.48 | 6.88 |
| Depreciation | 2.49 | 2.91 | 2.69 | 2.66 | 2.80 | 2.85 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.81 | 9.47 | 8.85 | -1.11 | 4.68 | 4.02 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.81 | 9.47 | 8.85 | -1.11 | 4.68 | 4.02 |
| EPS (Unit Curr.) | 3.14 | 16.45 | 15.37 | -1.93 | 8.13 | 6.99 |
| EPS (Adj) (Unit Curr.) | 3.14 | 16.45 | 15.37 | -1.93 | 8.13 | 6.99 |
| Calculated EPS (Unit Curr.) | 3.14 | 16.45 | 15.37 | -1.93 | 8.13 | 6.99 |
| Calculated EPS (Adj) (Unit Curr.) | 3.14 | 16.45 | 15.37 | -1.93 | 8.13 | 6.99 |
| Calculated EPS (Ann.) (Unit Curr.) | 12.55 | 65.78 | 61.48 | -7.72 | 32.53 | 27.96 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 12.55 | 65.78 | 61.48 | -7.72 | 32.53 | 27.96 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 1.15 | 1.15 | 1.15 | 1.15 | 1.15 | 1.15 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 10.02 | 21.97 | 21.41 | 4.25 | 15.47 | 16.12 |
| PBDTM(%) | 9.98 | 21.94 | 21.37 | 4.20 | 15.41 | 16.07 |
| PATM(%) | 4.21 | 16.79 | 16.40 | -3.01 | 9.64 | 9.39 |